Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
domingo, octubre 25
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Onconetix Inc
ONCO
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.4180
0.0112
2.75%
Últ. Act.: Oct 23, 7:42 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Onconetix Financials
Onconetix (ONCO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?
Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initiation and developments in prostate cancer diagnostics.
Mohd Haider
PRO
Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent increase over losses of $(225.25) per share from the same period last year. The company reported $21.457 thousand in sales
Benzinga Newsdesk
PRO
Onconetix Q3 EPS $(6.25) Up From $(249.05) YoY, Sales $303.651K Down From $406.859K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.25) per share. This is a 97.49 percent increase over losses of $(249.05) per share from the same period last year. The company reported $303.651 thousand in sales
Benzinga Newsdesk
PRO
Onconetix Q2 EPS $(4.76) Up From $(2.19 thousand) YoY, Sales $106.494K Down From $704.848K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(4.76) per share. This is a 99.78 percent increase over losses of $(2.19 thousand) per share from the same period last year. The company reported $106.494 thousand
Benzinga Newsdesk
Dow Surges Over 100 Points; Goldman Sachs Posts Upbeat Earnings
Avi Kapoor
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
Avi Kapoor
